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Abstract
Background: Life-threatening infections present major challenges for health systems in Malawi and the developing
world because routine microbiologic culture and sensitivity testing are not performed due to lack of capacity. Use
of empirical antimicrobial therapy without regular microbiologic surveillance is unable to provide adequate
treatment in the face of emerging antimicrobial resistance. This study was conducted to determine antimicrobial
susceptibility patterns in order to inform treatment choices and generate hospital-wide baseline data.
Methods: Culture and susceptibility testing was performed on various specimens from patients presenting with
possible infectious diseases at Kamuzu Central Hospital, Lilongwe, Malawi.
Results: Between July 2006 and December 2007 3104 specimens from 2458 patients were evaluated, with 60.1%
from the adult medical service. Common presentations were sepsis, meningitis, pneumonia and abscess. An
etiologic agent was detected in 13% of patients. The most common organisms detected from blood cultures were
Staphylococcus aureus, Escherichia coli, Salmonella species and Streptococcus pneumoniae, whereas Streptococcus
pneumoniae and Cryptococcus neoformans were most frequently detected from cerebrospinal fluid. Haemophilus
influenzae was rarely isolated. Resistance to commonly used antibiotics was observed in up to 80% of the isolates
while antibiotics that were not commonly in use maintained susceptibility.
Conclusions: There is widespread resistance to almost all of the antibiotics that are empirically used in Malawi.
Antibiotics that have not been widely introduced in Malawi show better laboratory performance. Choices for
empirical therapy in Malawi should be revised accordingly. A microbiologic surveillance system should be
established and prudent use of antimicrobials promoted to improve patient care.
Background
Life-threatening infections present major challenges for
health systems in the developing world. Managing these
infections requires accurate data on the prevalence of
specific causative organisms and their antimicrobial sus-
ceptibility profiles. However, microbiologic surveillance
data providing this crucial information are scarce. In
Malawi, a typical sub-Saharan African country, routine
microbiologic culture and sensitivity testing are not per-
formed due to lack of personnel, equipment and finan-
cial resources [1]. Instead, antimicrobial therapy is
empirical and a small repertoire of antimicrobials is
overused. This approach, although relatively inexpensive,
leads to the emergence of antibiotic resistance and
hence sub-optimal clinical outcomes. Antimicrobial
resistance in Malawi may also be occasioned by uncon-
trolled medical and veterinary use of antibiotics by the
private sector and the community.
Antimicrobial resistance, an emerging global public
health threat, is increasing worldwide and has been
reported in Malawi [2-5]. Of particular concern is the
reported resistance to many of the first-line antibiotics
for treating bacteraemia and other life-threatening infec-
tions [6]. However, some of these initial studies are now
outdated, had inadequate sample sizes, or were retro-
spective. Consequently, the problem of antimicrobial
resistance requires a more complete description [1,6-8].
At Kamuzu Central Hospital (KCH), Lilongwe, Malawi
we prospectively studied patients suspected of having an
infection in order to identify their causative organism
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method. This study was conducted to inform empirical
treatment choices and also to generate hospital-wide
baseline data.
Methods
Patients and study site
We conducted a cross-sectional study at KCH, a 750-
bed government medical centre serving Lilongwe district
(population 1,897,167) that also provides referral ser-
vices to the central region (population 5,491,034) [9].
The study period, from July 2006 to December 2007,
covered two dry seasons and one and a half rainy sea-
sons. During evaluation for admission, patients present-
ing with a suspected infection were evaluated using
appropriate microbiologic procedures. Specimens were
only collected at admission, and were not collected from
those seen on out-patient basis. This report includes
specimens from blood, cerebrospinal fluid (CSF), joint
fluid, bone biopsy, or pus collections.
We enrolled patients with pneumonia, meningitis,
bone and joint infections, peripartum infections and
other febrile clinical presentations (Table 1). Patients
who were already on antibiotics
1,t o os i c k
2 or unwill-
ing to undergo study procedures were excluded from
the study. Due to logistical constraints, patients present-
ing at night and on weekends were also excluded. All
laboratory analysis was conducted in the University of
North Carolina (UNC) Project laboratory at KCH. Insti-
tutional Review Boards in both Malawi and at UNC-
Chapel Hill approved the study and considered the col-
lection of biological samples for diagnostic purposes to
be the standard of care.
Prior to study implementation, information and
training sessions were held with the staff of Medicine,
Pediatrics, Surgery, and Obstetrics and Gynecology
departments. Content of the training sessions included
selection criteria for patient identification and appro-
priate sample collection techniques. Interpretation and
use of study results were discussed at clinical
meetings.
In each department, one lead staff member was identi-
fied to facilitate study implementation, including assur-
ance that all eligible patients were identified. A study
assistant was engaged full-time to track specimens from
around the hospital to the laboratory, return laboratory
results to the clinicians, manage study supplies and pro-
vide general logistical support to the study. We con-
ducted monthly review meetings with the lead staff
members to discuss study progress and address logistical
problems.
Table 1 Characteristics of Study Population (N = 2056)
Service Syndrome Total N (%)* Male N(%) Female N(%) Age Mean ± SD
Overall 2056 848 (43.3) 1110 (56.7) 26.0 ± 16.7
Paediatrics 543 254 218 4.4 ± 4.9
Febrile child 391 (89.5) 192 (90.6) 166 (87.8)
Neonates 46 (10.5) 20 (9.4) 23 (12.2)
Medicine 1213 506 692 34.8 ± 12.0
(adults) Meningitis 294 (25.1) 133 (27.4) 157 (23.3)
Pneumonia 360 (30.7) 116 (23.9) 240 (35.7)
Fever/sepsis 518 (44.2) 236 (48.7) 276 (41.0)
Obs/Gyn 127 0 127 24.7 ± 6.2
Meningitis 9 (7.5) 0 9 (7.5)
Pneumonia 7 (5.8) 0 7 (5.8)
Fever/sepsis 14 (11.7) 0 14 (11.7)
Prepartum sepsis 8 (6.7) 0 8 (6.7)
Puerperal sepsis 46 (38.3) 0 46 (38.3)
Gynaecological sepsis 36 (30.0) 0 36 (30.0)
Surgery 166 89 73 21.6 ± 15.8
(adults and children) Osteomyelitis 9 (5.7) 3 (3.6) 5 (7.2)
Necrotising fasciitis 3 (1.9) 2 (2.4) 1 (1.5)
Abdominal Abscess 84 (53.5) 42 (50.6) 40 (58.0)
Burn 8 (5.1) 3 (3.6) 5 (7.2)
Septic arthritis 53 (33.8) 33 (39.8) 18 (26.1)
*Categories may not sum to the total because of missing data
Makoka et al. BMC Infectious Diseases 2012, 12:67
http://www.biomedcentral.com/1471-2334/12/67
Page 2 of 8Data collection
We collected patient information on case record forms,
standardised for each department. Clinical information
included demographics, symptoms experienced in the
previous week, antibiotic use in the previous three
months, findings on physical examination, and clinical
diagnosis. Laboratory information included specimen(s)
collected, laboratory diagnosis, organisms identified and
antibiotic susceptibility results.
Laboratory methods
Specimens were collected on the clinical wards and
transported directly to the UNC Project Laboratory on
t h eg r o u n d so fK C H .T h el a b o r a t o r yp a r t i c i p a t e di n
external quality assurance scheme provided by the Col-
lege of American Pathologists. In general, only one
blood culture was collected per patient because of fund-
ing limitations. Specimens were processed within 2
hours of collection.
We used sheep blood, chocolate, malt and Mueller-
Hinton agar plates from commercial sources. MacCon-
key and mannitol salt agars were prepared in-house
from purchased dehydrated constituents. We did not
perform anaerobic cultures.
Blood cultures
The venipuncture site was disinfected with 70% alcohol
and 2% tincture of iodine before collecting approxi-
mately 10 ml of blood in adults and 3 ml of blood in
paediatric patients. Blood specimens were inoculated
into BBL™ SEPTI-CHEK™, with slides containing cho-
colate, MacConkey and Malt agars. The slides, too, were
inoculated and the set was incubated at 35 - 37°C in 5%
CO2. The bottles were inverted after 4 to 6 hours and
were examined daily for signs of growth. Cultures with
visible growth were assessed with gram stain. We used
the gram stain results to guide subcultures and suscept-
ibility testing by disc diffusion. Specimens with growth
were subcultured onto sheep blood agar plates. Speci-
mens with no growth after incubation for seven days
were declared ‘no growth’. All plates were incubated in
conditions similar to the bottles.
Cerebrospinal fluid (CSF)
The site was prepared as for venipuncture. Gram and
India ink stains were performed on CSF specimens.
Sheep blood and chocolate agars were also inoculated
and incubated at 35 - 37°C in 5% CO2 and were exam-
ined daily for seven days.
Biopsiesand swabs
Biopsies and/or swabs were obtained from bone, skin
and soft tissues. Gram stains were performed on all
biopsies and swabs. These specimens were cultured on
sheep blood, MacConkey and chocolate agars, incubated
at 35 - 37°C in 5% CO2 and examined daily for seven
days.
Processing of isolates
Isolates were identified and processed according to stan-
dard techniques (Table 2, 3) [10]. Antibiotic susceptibil-
ities were determined by disc diffusion on Mueller-
Hinton agar, interpreted according to the CLSI guide-
lines and quality-controlled using Escherichia coli ATCC
25922 and Staphylococcus aureus ATCC 25923 [11]. For
Streptococcus pneumoniae, Mueller-Hinton agar with 5%
sheep blood was used including an oxacillin screening
test to determine reduced susceptibility to S. pneumo-
niae [11]. Minimum inhibitory concentrations were not
performed.
Contaminants
Coagulase negative staphylococci, Bacillus spp and dip-
threoids were considered contaminants when recovered
from any specimen.
Malaria testing
Malaria testing using thick and thin blood films was
conducted on a stat basis in a mini-laboratory located in
the consultations area. However, results for this test
were not collated with the laboratory analyses described
above.
Data analyses
All data were entered into a Microsoft Office Access
2003 database. Statistical analyses were performed using
Stata, version 10.0. The data were described using uni-
variable frequencies, distributions and measures of cen-
tral tendency. We used Fisher’s exact test or Pearson’s
chi-square test for bivariable comparisons of categorical
data.
Ethical considerations
The protocol for this study was approved by Malawi’s
National Health Sciences Research Committee and the
Institutional Review Board of the University of North
Carolina at Chapel Hill School of Medicine. Informed
consent was not sought because the procedures that
were involved in this study were deemed to constitute
standard patient care. The results from the study were
used to inform patient care.
Results
Characteristics of the study population
During the study period, 2236 specimens were sub-
mitted from 2056 patients. Most were seen on the adult
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included 848 males and 1110 females. The mean age
was 34.8 years for adult medical patients, 4.4 for pedia-
tric medical patients, 21.6 for all surgery patients, and
24.7 for obstetrics/gynecology patients. Common syn-
dromes included sepsis, meningitis, pneumonia, and
among surgery patients, abscess.
Blood culture yield
The yield of blood cultures in our patient population was
high at 12.7% (Table 4). The proportion of blood cultures
yielding skin contaminants was 9.2%. Among those with
positive blood cultures, the organisms identified differed
between the pediatric and medical services (p ≤ 0.0001).
The most common organisms recovered from blood cul-
tures of children were S. aureus (48%), gram negative
bacilli including E. coli and Salmonella species (26%) and
S. pneumoniae (17%). Salmonella isolates were not
further distinguished into Typhi and non-Typhi Salmo-
nella. In contrast, among adults on the medical ward S.
pneumoniae (33%), gram negative bacilli (27%) and S.
aureus ( 2 3 % )w e r em o s tc o m m o n l yi s o l a t e d .Haemophi-
lus influenzae was isolated once from a child.
Other specimens
S. aureus was also most frequently isolated from
abscesses, bones and joints (Table 5). From cerebrosp-
inal fluid S. pneumoniae and C. neoformans were the
predominant pathogens (Table 5).
Antibiotic resistance
O v e ro n e - t h i r do fg r a mp o s i t i v eb a c t e r i aw e r er e s i s t a n t
to the commonly used antibiotics (chloramphenicol,
ampicillin, tetracycline, trimethoprim/sulfamethoxazole,
gentamicin, and erythromycin) while for gram negative
this proportion was higher (Table 3). Clindamycin gave
Table 2 Laboratory methods for identification and susceptibility testing
Organism Media Tests for presumptive identification Susceptibility panel Method
Salmonellae BAP Gram stain; GNP Disc diffusion
MAC TSI;
Indole;
Colony morphology;
Urease
Enteric gram negative bacilli BAP Gram stain; GNP Disc diffusion
MAC Colony morphology
Indole;
Oxidase;
TSI;
Citrate;
Urease
N. meningitidis BAP Gram stain None None
CHOC Oxidase
TM Thayer-Martin
S. pneumoniae BAP Gram stain GPP Disc diffusion
CHOC Hemolysis Catalase Oxacillin
Bile solubility screening test
S. aureus BAP Gram stain GPP Disc diffusion
CHOC Catalase Oxacillin
MSA Coagulase
Staphlex
C. neoformans Sabouraud’s Gram stain None None
BAP India Ink
Urease
Haemophilus BAP Gram stain None None
CHOC Oxidase
API-NH
S. pyogenes BAP Haemolysis GPP Disc diffusion
Gram stain
BAP = blood agar plate, MAC = MacConkey agar, CHOC = chocolate agar, TSI = triple-sugar with iron media, TM = Thayer-Martin agar, MSA = mannitol salt agar.
Coagulase = tube coagulate test using human plasma; GPP = gram positive antibiotic panel, GNP = gram negative antibiotic panel, see Table 3.
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against S. aureus in particular and also comparably
against gram positive bacteria, while ceftriaxone and
ciprofloxacin gave best results against the gram nega-
tives. S. pneumoniae was highly resistant to cotrimoxa-
zole, but remained susceptible to erythromycin, while
Salmonella was resistant to chloramphenicol, ampicillin
and trimethoprim/sulfamethoxazole but susceptible to
ceftriaxone (Table 3).
* Isolates with oxacillin zone size of < 20 mm were
considered penicillin non-susceptible (some of which
would have shown susceptibility under MIC testing)
†Isolates displaying resistance induced by erythromy-
cin, i.e., positive D-test, were considered clindamycin
resistant.
Tmp-Sxt = co-trimoxazole.
Discussion and Conclusions
We conducted a large, cross-sectional microbiologic
study of patients with presumed infections seen at a
large medical centre in Malawi. We observed that the
common bacterial causes of bacteraemia differ between
children and adults, and that S. aureus is extremely
common in blood, abscesses, joints, and bone. We also
observed widespread antimicrobial resistance to com-
monly used antibiotics.
Our findings highlight the variation in bacteremia
etiology, both geographically and temporally, within
sub-Saharan Africa [8,12,13]. In our setting, gram posi-
tive bacteria, especially S. aureus and S. pneumoniae,
were the most common cause of bacteraemia and infec-
tions of other anatomic sites. An earlier study in neo-
nates in Malawi observed a predominance of Salmonella
and other gram negative bacilli in patients with bactere-
mia [12]. We also isolated S. aureus more commonly
than was observed elsewhere [7,14]. However, in The
Gambia, S. aureus and S. pneumoniae caused almost
three quarters of bacteraemia cases in an urban hospital
[15]. In addition, this is a population which did not
receive the pneumococcal conjugate vaccine.
Our observation that S. aureus was the most com-
monly isolated organism must be interpreted cautiously.
Robust organisms, such as S. aureus and Salmonella, are
more likely to be isolated than fastidious ones [16].
Thus, the prevalence of the robust organisms could pos-
sibly be biased upwards. However, we frequently isolated
S. pneumoniae, a less robust organism, which suggests
that our aerobic culture techniques were adequate.
Although we had relatively few CSF cultures, the
results were highly informative. C. neoformans was a
common cause of meningitis, second only to S. pneumo-
niae. The high prevalence of Cryptococcus was most
likely due to a high prevalence of HIV infection in the
Table 3 Antibiotic resistant bacteria isolated from all specimens
Gram positive organisms S. aureus S. pneumoniae
Antibiotic Resistant n/N (%) Resistant + Intermediate n/N (%) Resistant n/N (%) Resistant n/N (%)
Chloramphenicol 59/171 (34.5) 77/171 (45.0) 30/95 (31.6) 17/51 (33)
Clindamycin 19/188 (10.1) 72/188 (38.3) 14/143 (9.8)
† 3/30 (10.0)
†
Erythromycin 62/220 (28.2) 112/220 (50.9) 51/122 (41.8) 1/67 (1.5)
Gentamicin 60/183 (32.8) 77/183 (42.1) 28/141 (19.9) 23/27 (85.2)
Oxacillin 70/230 (30.4) 84/230 (36.5) 46/147 (31.3) 11/59 (18.6)*
Tetracycline 135/222 (60.8) 150/222 (67.6) 81/129 (62.8) 32/63 (50.8)
Tmp-Sxt 149/199 (74.9) 158/199 (79.4) 88/127 (69.3) 42/47 (89.4)
Gram negative organisms Salmonella spp.
Resistant n/N (%) Resistant + Intermediate n/N (%) Resistant n/N (%) Resistant + Intermediate n/N (%)
Chloramphenicol 49/69 (71.0) 52/69 (75.4) 12/17 (70.1) 12/17 (70.6)
Gentamicin 27/80 (33.8) 31/80 (38.8) 0/19 (0.0) 2/19 (10.5)
Tmp-Sxt 53/65 (81.5) 54/65 (83.1) 12/15 (80.0) 12/15 (80.0)
Ampicillin 65/84 (77.4) 69/84 (82.1) 18/21 (85.7) 18/21 (85.7)
Ceftriaxone 16/85 (18.8) 29/85 (34.1) 0/20 (5.0) 1/20 (5.0)
Ciprofloxacin 9/75 (12.0) 20/75 (26.7) 0/22 (0.0) 0/22 (0.0)
Nalidixic acid 26/79 (32.9) 44/79 (55.7) 0/20 (0.0) 9/20 (45.0)
Table 4 Recovery of pathogens from clinical specimens
†
Specimen type Positive
(%)
No growth
(%)
Contaminated
(%)
Total
Blood 241 (12.7) 1479 (78.1) 174 (9.2) 1894
Cerebrospinal
fluid
23 (15.2) 128 (84.8) 0 151
Joint fluid 13 (21.7) 47 (78.3) 0 60
Pus 86 (72.3) 30 (25.2) 3 (2.5)* 119
Bone 7 (58.3) 5 (41.7) 0 12
†Repeat specimens were not done, and when an isolate was recovered from
different specimens they were all counted. * Includes coagulase negative
staphylococci and normal flora
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of medical inpatients are HIV infected. We can not
comment on the frequency of tuberculous meningitis
since culture for that organism was not attempted in
this study population. We also observed very few cases
of Haemophilus influenzae meningitis or bacteraemia,
possibly due to the introduction of routine childhood H.
influenzae b vaccination in 2002. Neisseria meningitidis
also was not recovered reflecting this as a rare cause of
meningitis in this population.
We found widespread bacterial resistance to almost all
of our commonly used antibiotics. Our findings contrast
starkly with the limited resistance observed in Malawi
between 1996 and 2001, although resistance to first line
antibiotics for bacteremia was observed over a decade ago
[6,12]. Of particular concern is high incidence of bacterae-
mia caused by non-Typhi Salmonella, which has increased
with development of multi-drug resistance [17]. In our set-
ting, Salmonella is a common gram negative bacterium
infecting blood and joints and it was susceptible to genta-
micin and ceftriaxone in vitro. The problem of fluoroqui-
nolone resistance in Salmonella enterica serotypes other
than Typhi is not well studied in Africa.
In a separate Malawi study, no fluoroquinolone resis-
tance was reported among Salmonella isolates [17]. In a
study from Senegal, approximately 5% of isolates showed
low level fluoroquinolone resistance [18]. We found none
of the 25 Salmonella isolates tested to be nalixidic acid
resistant although interestingly close to half (11/25) were
nalidixic acid intermediate (Table 3). A previous study
suggests Salmonella strains with intermediate susceptibil-
ity by disk diffusion may have MICs in a range consistent
with low level ciprofloxacin resistance [19]. Unfortunately
ciprofloxacin MICs were not available to determine if
these nalidixic acid intermediate isolates did, in fact, have
low level ciprofloxacin resistance. This issue deserves close
scrutiny in the coming years.
Our findings of widespread antimicrobial resistance
have a strong bearing on the current treatment choices.
Malawi, like most resource poor countries, does not
provide routine microbiologic culture and sensitivity test-
ing [3]. Instead, the Malawi National Treatment Guide-
lines provides for initiation of antimicrobial therapy
empirically, based on clinical observation and history,
which is often broad spectrum [16,20-23]. However, the
development of antimicrobial resistance in this context
can have major clinical consequences. In Tanzania, anti-
microbial resistance was a significant risk for death in
children with bacteremia [23]. Antimicrobial resistance
can also lead to treatment failures, prolonged drug treat-
ment courses and protracted hospital admissions [23].
Considering the potential consequences of increased
antimicrobial resistance, our findings support a review
of the current antibiotic choices in Malawi. Of the anti-
biotics we examined, only three are not widely used and
show good susceptibility. Ceftriaxone and ciprofloxacin
retain activity against gram negative bacteria, including
Salmonella spp. Gram positive organisms, including S.
aureus and S. pneumoniae, remain susceptible to clinda-
mycin, and may also be susceptible to third-generation
cephalosporins. Revision of the national treatment
guidelines with inclusion of clindamycin, and ciprofloxa-
cin or ceftriaxone, coupled with promotion of their pru-
dent use, should improve patient outcomes and
potentially save costs of providing clinical services.
This study represents an account of community-
acquired infections in that it included only specimens
collected at admission, and did not include subsequent
specimens and specimens from patients who had already
been on antimicrobial therapy prior to presentation.
Unfortunately, we were unable to include patients who
presented to the hospital outside of the daytime hours,
due to the constraints of study personnel. In addition,
the maternity ward was located outside the main hospi-
tal campus, limiting the enrolment of patients there.
Thus, our study population was not a complete assess-
ment of all infections presenting to KCH during the
study period. Also clinical outcomes were not collected
to triangulate our laboratory findings. More advanced
microbiologic testing such as minimum inhibitory
Table 5 Organisms recovered from different specimens
Organism Blood n (%) CSF n (%) Joint n (%) Bone n (%) Pus n (%) Total n (%)
S. aureus 92 (39.0) 0 5 (38.5) 3 (42.9) 54 (62.8) 154 (42.0)
S. pneumoniae 56 (23.5) 10 (43.5) 3 (23.1) 0 1 (1.2) 70 (19.1)
Streptococcus spp. 20 (8.4) 1 (4.4) 2 (15.4) 2 (28.6) 11 (12.8) 36 (9.8)
Salmonella spp 20 (8.4) 1 (4.4) 3 (23.1) 0 0 24 (6.5)
Gram negative bacilli* 43 (18.5) 2 (8.7) 0 2 (28.6) 20 (23.2) 68 (18.5)
N. meningitidis 2 (0.8) 0 0 0 0 2 (0.5)
C. neoformans 2 (0.8) 9 (39.1) 0 0 0 11 (3.0)
Yeast/Candida 2 (0.8) 0 0 0 0 2 (0.5)
Total 238 (100) 23 (100) 13 (100) 7 (100) 86 (100) 367 (100)
* includes E. coli, Klebsiella, Proteus, Pseudomonas, Citrobacter, Yersinia and Acinetobacter
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mases (ESBLs), which would have helped refine some of
our basic findings, were not performed. Nonetheless, we
were able to enrol a large number of patients with a
diverse spectrum of clinical syndromes and also perform
basic identification and antimicrobial susceptibility test-
ing. Consequently, our results provide a large microbio-
logic assessment of bacterial infections in Malawi.
The widespread antimicrobial resistance in our study
is concerning. Choices for empirical therapy in Malawi
should be revised accordingly. Newer antibiotics, though
more costly, must be used more widely, but judiciously,
to limit the further spread of antimicrobial resistance.
The establishment of a dependable, accurate and timely
microbiological service and surveillance system along
with optimal use of this service by the clinicians should
considerably improve the care of patients. Finally, pru-
dent use of antimicrobials should be promoted.
Notes
1 As a referral hospital, some patients seen at KCH were
already on antibiotics.
2 Due to lack of routine diagnostic culture, especially
blood cultures, patient perception to collection of these
specimens are not always favourable, and untoward out-
come in a patient who was already critically ill may be
attributed to the specimen collection procedure. The
effect of this exclusion has not been quantified but may
be minimal.
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